Healthcare ❯ Pharmaceuticals ❯ Biotechnology

Drug Development

Eli Lilly Eylea VYJUVEK AI in Healthcare EYLEA HD Psoriasis Treatments Bristol-Myers Squibb Metsera Immunology Drugs Clinical Trials Kiniksa Pharmaceuticals Alzheimer's Disease Patient Care Novo Nordisk Market Trends Cancer Therapies Market Analysis

Baron Health Care Fund Falls 6.97% in Q1, Repositions for Long-Term Growth

The quarterly letter signals a shift toward companies tied to aging populations to ride out near-term volatility.

Cyclerion to Merge With Korsana in Reverse Takeover Backed by $380 Million

Krystal Biotech Posts Strong Q4 as VYJUVEK Hits $107 Million, Pivots 2026 Growth to Ex‑U.S. Markets

Regeneron Beats Q4 and Charts 2026 Catalysts With FDA Decisions and Phase III Push

Eli Lilly Unveils $3 Billion Netherlands Plant for Oral GLP-1 Medicines as Stock Rises